Swollen ankles—sometimes also known as peripheral edema—occur when there is an abnormal build-up of fluid in the tissues of the lower legs. Anyone can develop swollen ankles, but older people, those ...

If the number of recent drug approvals for atopic dermatitis (AD) is overwhelming, the future is unlikely to be any less ...

ALBAWABA Your feet can reveal a lot about your overall health, including potential problems with your heart. Since the heart ...

peripheral edema, rash, infusion-related reaction, insomnia and COVID-19 infection. Sarclisa was approved by the FDA in 2020 ...

In addition to other MM indications, Isatuximab's anti-CD38 competitor on the US market, daratumumab (Darzalex — Johnson & ...

Type 2 diabetes is a form of diabetes characterized by high blood sugar (glucose), insulin resistance, and a decrease in insulin production. For some people, type 2 diabetes can be managed with ...

Daratumumab plus VRd is a more effective frontline treatment option for patients who cannot undergo immediate transplant, ...

The FDA approved isatuximab plus bortezomib, lenalidomide, and dexamethasone for patients with newly diagnosed myeloma who ...

A new generation of catheters with a longer balloon, longer working length, and more pulses to manage calcified peripheral ...

BOSTON & MONTREAL, September 26, 2024--enGene Holdings Inc. (Nasdaq: ENGN or "enGene" or the "Company"), is a clinical-stage ...

Adjuvant cancer treatments such as chemotherapy and radiation are given after a primary cancer treatment to help prevent ...

The Food and Drug Administration (FDA) has approved Sarclisa ® (isatuximab-irfc) in combination with bortezomib, lenalidomide and dexamethasone (VRd) for the treatment of patients with newly diagnosed ...